3,021
Views
98
CrossRef citations to date
0
Altmetric
Review Series: Cryopreservation

Clinical grade adult stem cell banking

, &
Pages 143-154 | Published online: 01 Jul 2009

References

  • Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 2006; 12:3007 - 3019
  • Klingemann H, Matzilevich D, Marchand J. Mesenchymal stem cells-sources and clinical applications. Transfus Med Hemother 2008; 35:272 - 277
  • Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008; 2:169 - 183
  • Korbling M, Estrov Z. Adult stem cells for tissue repair—a new therapeutic concept?. N Engl J Med 2003; 349:570 - 582
  • Woods EJ, Pollok KE, Byers MA, Perry BC, Purtteman J, Heimfeld S, et al. Cord blood stem cell cryopreservation. Transfus Med Hemother 2007; 34:276 - 285
  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7:211 - 228
  • Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109:235 - 242
  • Campagnoli C, Roberts IAG, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver and bone marrow. Blood 2001; 98:2396 - 2402
  • in 't Anker PS, Scherjon SA, Keur CK-vd, Groot-Swings GMd, Claas FHJ, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22:1338 - 1345
  • Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and invivo. Proc Natl Acad Sci USA 2000; 97:13625 - 13630
  • Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22:1330 - 1337
  • Brooke G, Rossetti T, Pelekanos R, Ilic N, Murray P, Hancock S, et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol 2009; 144:571 - 579
  • Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 2007; 18:846 - 858
  • Strem BM, Hedrick MH. The growing importance of fat in regenerative medicine. Trends Biotechnol 2005; 23:64 - 66
  • Vallee M, Cote JF, Fradette J. Adipose-tissue engineering: taking advantage of the properties of human adipose-derived stem/stromal cells. Pathol Biol (Paris) 2009; 57:309 - 317
  • Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121:368 - 374
  • Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 2006; 24:1294 - 1301
  • Zhang Y, Li CD, Jiang XX, Li HL, Tang PH, Mao N. Comparison of mesenchymal stem cells from human placenta and bone marrow. Chin Med J (Engl) 2004; 117:882 - 887
  • Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005; 52:2521 - 2529
  • Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue and umbilical cord blood. Exp Hematol 2005; 33:1402 - 1416
  • Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, et al. Comparison of human placenta and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008; 17:1095 - 1107
  • Li G, Zhang XA, Wang H, Wang X, Meng CL, Chan CY, et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord and placenta: implication in the migration. Proteomics 2009; 9:20 - 30
  • Musina R, Bekchanova E, Belyavskii A, Sukhikh G. Differentiation potential of mesenchymal stem cells of different origin. B Exp Biol Med 2006; 141:147 - 151
  • Kevin G, Connie F, Sharp JG, Ann B. Does the Number or Quality of Pluripotent Bone Marrow Stem Cells Decrease with Age?. C Orthod Relat R 2007; 465:202 - 207
  • Muschler GF, Boehm C, Easley K. Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume. J Bone Joint Surg Am 1997; 79:1699 - 1709
  • Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103:4619 - 4621
  • Noel D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 2007; 48:1283 - 1289
  • Thirumala S, Zvonic S, Floyd E, Gimble JM, Devireddy RV. Effect of various freezing parameters on the immediate post-thaw membrane integrity of adipose tissue derived adult stem cells. Biotechnol Prog 2005; 21:1511 - 1524
  • Woods EJ, Perry BC, Hockema JJ, Larson L, Zhou D, Goebel WS. Optimized cryopreservation method for human dental pulp-derived stem cells and their tissues of origin for banking and clinical use. Cryobiology 2009;
  • Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100:1249 - 1260
  • Bosse R, Singhofer-Wowra M, Rosenthal F, Schulz G. Good manufacturing practice production of human stem cells for somatic cell and gene therapy. Stem Cells 1997; 15:275 - 280
  • Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 2008; 17:48 - 53
  • Thirumala S, Gimble JM, Devireddy RV. Transport phenomena during freezing of adipose tissue derived adult stem cells. Biotechnol Bioeng 2005; 92:372 - 383
  • Goh BC, Thirumala S, Kilroy G, Devireddy RV, Gimble JM. Cryopreservation characteristics of adipose-derived stem cells: maintenance of differentiation potential and viability. J Tissue Eng Regen Med 2007; 1:322 - 324
  • Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007; 25:1270 - 1278
  • Liu G, Zhou H, Li Y, Li G, Cui L, Liu W, et al. Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 2008; 57:18 - 24
  • Fuller BJ. Cryoprotectants: the essential antifreezes to protect life in the frozen state. Cryo Letters 2004; 25:375 - 388
  • Fuller R, Devireddy RV. The effect of two different freezing methods on the immediate post-thaw membrane integrity of adipose tissue derived stem cells. Int J Heat Mass Tran 51:5650 - 5654
  • Devireddy RV, Thirumala S, Gimble JM. Cellular response of adipose derived passage-4 adult stem cells to freezing stress. J Biomech Eng 2005; 127:1081 - 1086
  • Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. P Natl Acad Sci USA 1995; 92:10119 - 10122
  • Perry BC, Zhou D, Wu X, Yang FC, Byers MA, Chu TM, et al. Collection, cryopreservation and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. Tissue Eng Part C Methods 2008; 14:149 - 156
  • Fleming KK, Hubel A. Cryopreservation of hematopoietic and non-hematopoietic stem cells. Transfus Apher Sci 2006; 34:309 - 315
  • Buchanan SS, Gross SA, Acker JP, Toner M, Carpenter JF, Pyatt DW. Cryopreservation of stem cells using trehalose: evaluation of the method using a human hematopoietic cell line. Stem Cells Dev 2004; 13:295 - 305
  • Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23:533 - 537
  • Liseth K, Abrahamsen JF, Bjorsvik S, Grottebo K, Bruserud O. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Cytotherapy 2005; 7:328 - 333
  • Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000; 25:1299 - 1301
  • Higman MA, Port JD, Beauchamp NJ Jr, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26:797 - 800
  • Windrum P, Morris TCM. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31:315
  • Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005; 36:601 - 603
  • Young DA, Gavrilov S, Pennington CJ, Nuttall RK, Edwards DR, Kitsis RN, et al. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes. Biochem Bioph Res Co 2004; 322:759 - 765
  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61:364 - 370
  • Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM, et al. Long-term storage at −80°C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999; 39:70 - 73
  • Bakken AM, Bruserud O, Abrahamsen JF. No differences in colony formation of peripheral blood stem cells frozen with 5 or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 2003; 12:351 - 358
  • Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, et al. Uncontrolled-rate freezing and storage at −80°C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001; 667 - 673
  • Lakota J, Fuchsberger P. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 1996; 18:262 - 263
  • Curcoy AI, Alcorta I, Estella J, Rives S, Toll T, Tuset E. Cryopreservation of HPCs with high cell concentration in 5-percent DMSO for transplantation to children. Transfusion 2002; 42:962
  • Zhao J, Hao HN, Thomas RL, Lyman WD. An efficient method for the cryopreservation of fetal human liver hematopoeitic progenitor cells. Stem Cells 2001; 19:212 - 218
  • Beaujean F, Bourhis JH, Bayle C, Jouault H, Divine M, Rieux C, et al. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Bone Marrow Transplant 1998; 22:1091 - 1096
  • Richter E, Eichler H, Raske D, Leveringhaus A, Zieger W, Kerowgan M, et al. 5% Me2SO is sufficient to preserve stem cells derived from cord blood. Bone Marrow Transplant 1998; 22:16
  • Sputtek A, Jetter S, Hummel K, Kühnl P. Cryopreservation of peripheral blood progenitor cells: Characteristics of suitable techniques. Beitr Infusionsther Transfusionsmed 1997; 34:79 - 83
  • Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002; 42:1573 - 1580
  • Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987; 70:974 - 978
  • Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physio 2007; 213:18 - 26
  • Bruserud O, Tronstad KJ, Berge R. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J Cancer Res Clin Oncol 2005; 131:377 - 384
  • Yamamoto N, Isobe M, Negishi A, Yoshimasu H, Shimokawa H, Ohya K, et al. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci 2003; 50:63 - 69
  • Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004; 32:1212 - 1225
  • Kobayashi T, Watanabe H, Yanagawa T, Tsutsumi S, Kayakabe M, Shinozaki T, et al. Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. J Bone Joint Surg Br 2005; 87:1426 - 1433
  • Matsuo A, Yamazaki Y, Takase C, Aoyagi K, Uchinuma E. Osteogenic potential of cryopreserved human bone marrow-derived mesenchymal stem cells cultured with autologous serum. J Craniofac Surg 2008; 19:693 - 700
  • Kawano Y, Lee CL, Watanabe T, Abe T, Suzuya H, Okamoto Y, et al. Cryopreservation of mobilized blood stem cells at a higher cell concentration without the use of a programmed freezer. Ann Hematol 2004; 83:50 - 54
  • Reuther T, Kettmann C, Scheer M, Kochel M, Iida S, Kübler AC. Cryopreservation of osteoblast-like cells: viability and differentiation with replacement of fetal bovine serum in vitro. Cells Tissues Organs 2006; 183:32 - 40
  • Dimarakis I, Levicar N. Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research. Stem Cells 2006; 24:1407 - 1408
  • Liu CH, Wu ML, Hwang SM. Optimization of serum free medium for cord blood mesenchymal stem cells. Biochem Eng J 2007; 33:1 - 9
  • Pochampally RR, Smith JR, Ylostalo J, Prockop DJ. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 2004; 103:1647 - 1652
  • Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995; 85:929 - 940
  • Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 1997; 97:561 - 570
  • Foreman MA, Smith J, Publicover SJ. Characterisation of serum-induced intracellular Ca2 oscillations in primary bone marrow stromal cells. J Cell Physiol 2006; 206:664 - 671
  • Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006; 24:416 - 425
  • Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7:29
  • Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 2007; 13:1477 - 1486
  • MacRae JW, Tholpady SS, Ogle RC, Morgan RF. Ex Vivo Fat Graft Preservation: Effects and Implications of Cryopreservation. Ann Plas Surg 2004; 52:281 - 282
  • Moscatello DK, Dougherty M, Narins RS, Lawrence N. Cryopreservation of human fat for soft tissue augmentation: viability requires use of cryoprotectant and controlled freezing and storage. Dermatol Surg 2005; 31:1506 - 1510
  • Matsumoto D, Shigeura T, Sato K, Inoue K, Suga H, Kato H, et al. Influences of Preservation at Various Temperatures on Liposuction Aspirates. Plast Reconstr Surg 2007; 120:1510 - 1517
  • Cui XD, Gao DY, Fink BF, Vasconez HC, Pu LL. Cryopreservation of human adipose tissues. Cryobiology 2007; 55:269 - 278
  • Pu LL, Cui X, Fink BF, Cibull ML, Gao D. Long-term preservation of adipose aspirates after conventional lipoplasty. Aesthet Surg J 2004; 24:536 - 541
  • Pu LL, Cui X, Fink BF, Cibull ML, Gao D. Cryopreservation of adipose tissues: the role of trehalose. Aesthet Surg J 2005; 25:126 - 131
  • Pu LL, Cui X, Li J, Fink BF, Cibull ML, Gao D. The fate of cryopreserved adipose aspirates after in vivo transplantation. Aesthet Surg J 2006; 26:653 - 661
  • Chan CW, McCulley SJ, Macmillan RD. Autologous fat transfer—a review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aes 2008; 61:1438 - 1448
  • Pu LL, Cui X, Fink BF, Gao D, Henry VC. Adipose aspirates as a source for human processed lipoaspirate cells after optimal cryopreservation. Plast Reconstr Surg 2006; 117:1845 - 1850
  • Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and invivo. P Natl Acad Sci USA 2000; 97:13625 - 13630
  • Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, et al. SHED: Stem cells from human exfoliated deciduous teeth. P Natl Acad Sci USA 2003; 100:5807 - 5812
  • Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005; 80:836 - 842
  • Zhang W, Walboomers XF, Shi S, Fan M, Jansen JA. Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng 2006; 12:2813 - 2823
  • Papaccio G, Graziano A, d'Aquino R, Graziano MF, Pirozzi G, Menditti D, et al. Long-term cryopreservation of dental pulp stem cells (SBP-DPSCs) and their differentiated osteoblasts: a cell source for tissue repair. J Cell Physiol 2006; 208:319 - 325
  • Woods EJ, Benson JD, Agca Y, Critser JK. Fundamental cryobiology of reproductive cells and tissues. Cryobiology 2004; 48:146 - 156
  • Okamoto T, Yatsuzuka N, Tanaka Y, Kan M, Yamanaka T, Sakamoto A, et al. Growth and differentiation of periodontal ligament-derived cells in serum-free defined culture. In Vitro Cell Dev Biol Anim 1997; 33:302 - 309
  • Suchanek J, Soukup T, Visek B, Ivancakova R, Kucerova L, Mokry J. Dental pulp stem cells and their characterization. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009; 153:31 - 35
  • Seo B-M, Miura M, Sonoyama W, Coppe C, Stanyon R, Shi S. Recovery of Stem Cells from Cryopreserved Periodontal Ligament. J Dent Res 2005; 84:907 - 912
  • Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008; 26:300 - 311
  • Zhang Y, Li CD, Jiang XX, Li HL, Tang PH, Mao N. Comparison of mesenchymal stem cells from human placenta and bone marrow. Chin Med J (Engl) 2004; 117:882 - 887
  • Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, et al. Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Bio Int 2006; 30:681 - 687
  • Yen BL, Chien CC, Chen YC, Chen JT, Huang JS, Lee FK, et al. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng Part A 2008; 14:9 - 17
  • Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH, et al. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 2006; 24:1759 - 1768
  • Miki T, Strom S. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev Rep 2006; 2:133 - 141
  • Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007; 1:296 - 305
  • Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004; 78:1439 - 1448
  • Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22:649 - 658
  • Huang YC, Yang ZM, Chen XH, Tan MY, Wang J, Li XQ, et al. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev Rep 2009;
  • Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004; 6:543 - 553
  • Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, et al. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 2006; 340:944 - 952
  • De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100 - 106
  • Delo DM, De Coppi P, Bartsch G Jr, Atala A. Amniotic fluid and placental stem cells. Methods Enzymol 2006; 419:426 - 438
  • Wulf GG, Viereck V, Hemmerlein B, Haase D, Vehmeyer K, Pukrop T, et al. Mesengenic progenitor cells derived from human placenta. Tissue Eng 2004; 10:1136 - 1147
  • Tamagawa T, Ishiwata I, Saito S. Establishment and Characterization of a Pluripotent Stem Cell line Derived from Human Amniotic Membranes and Initiation of Germ Layers in vitro. Hum Cell 2004; 17:125 - 130
  • Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007; 25:646 - 654
  • Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93:339 - 346
  • Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007; 13:1173 - 1183
  • Brooke G, Rossetti T, Ilic N, Murray P, Hancock S, Pelekanos R, et al. Points to consider in designing mesenchymal stem cell-based clinical trials. Transfus Med Hemoth 2008; 35:279 - 285
  • Kunisaki SM, Armant M, Kao GS, Stevenson K, Kim H, Fauza DO. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 2007; 42:974 - 979
  • Banas RA, Trumpower C, Bentlejewski C, Marshall V, Sing G, Zeevi A. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol 2008; 69:321 - 328
  • Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 2007; 75:279 - 291
  • Steigman SA, Armant M, Bayer-Zwirello L, Kao GS, Silberstein L, Ritz J, et al. Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg 2008; 43:1164 - 1169
  • Woodbury D, Kramer BC, Reynolds K, Marcus AJ, Coyne TM, Black IB. Long-term cryopreserved amniocytes retain proliferative capacity and differentiate to ectodermal and mesodermal derivatives in vitro. Mol Reprod Dev 2006; 73:1463 - 1472
  • Hennerbichler S, Reichl B, Pleiner D, Gabriel C, Eibl J, Redl H. The influence of various storage conditions on cell viability in amniotic membrane. Cell and Tissue Bank 2007; 8:1 - 8
  • Hunt CJ, Armitage SE, Pegg DE. Cryopreservation of umbilical cord blood: 2. Tolerance of CD34(+) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing. Cryobiology 2003; 46:76 - 87
  • Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996; 18:725 - 731
  • Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at −196°C by vitrification. Nature 1985; 313:573 - 575
  • Hunt C. The Banking and Cryopreservation of Human Embryonic Stem Cells. Transfusion Medicine and Hemotherapy 2007; 34:293 - 304
  • Check JH. Advances in oocyte cryopreservation—part II: rapid cooling using vitrification. Clin Exp Obstet Gynecol 2009; 36:5 - 9
  • Kurata H, Takakuwa K, Tanaka K. Vitrification of hematopoietic progenitor cells obtained from human cord blood. Bone Marrow Transplant 1994; 14:261 - 263
  • Moon JH, Lee JR, Jee BC, Suh CS, Kim SH, Lim HJ, et al. Successful vitrification of human amnion-derived mesenchymal stem cells. Human Reproduction 2008; 23:1760 - 1770
  • Leibo SP, Farrant J, Mazur P, Hanna MG Jr, Smith LH. Effects of freezing on marrow stem cell suspensions: interactions of cooling and warming rates in the presence of PVP, sucrose or glycerol. Cryobiology 1970; 6:315 - 332
  • Rollig C, Babatz J, Wagner I, Maiwald A, Schwarze V, Ehninger G, et al. Thawing of cryopreserved mobilized peripheral blood—comparison between waterbath and dry warming device. Cytotherapy 2002; 4:551 - 555
  • Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997; 19:283 - 287
  • Altman SA, Randers L, Rao G. Comparison of try-pan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 1993; 9:671 - 674
  • Humpe A, Beck C, Schoch R, Kneba M, Horst H-A. Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining. Transfusion 2005; 45:1208 - 1213
  • Baust JM, Van Buskirk RG, Baust JG. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell Dev Biol Anim 2000; 36:262 - 270
  • Baust JM, Van Buskirk RG, Baust JG. Gene activation of the apoptotic caspase cascade following cryogenic storage. Cell Preservation Technology 2002; 1:63 - 80
  • Mathew AJ, Baust JG, Van Buskirk RG. Improved hypothermic preservation of human renal cells through suppression of both apoptosis and necrosis. Cell Preservation Technology 2003; 1:239 - 253
  • de Boer F, Drager AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, et al. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 29:249 - 255
  • Sparrow RL, Komodromou H, Tippett E, Georgakopoulos T, Xu W. Apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood detected by the fluorescent vital dye SYTO 16 and correlation with loss of L-selectin (CD62L) expression. Bone Marrow Transplant 2006; 38:61 - 67
  • Cobo F, Stacey GN, Hunt C, Cabrera C, Nieto A, Montes R, et al. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol 2005; 68:456 - 466
  • Kenneth EA, Carmen MW. Cryopreservation: Applications in Pharmaceuticals and Biotechnology. Informa HealthCare 1999; 5
  • Stacey GN, Masters JR. Cryopreservation and banking of mammalian cell lines. Nat Protoc 2008; 3:1981 - 1989
  • Fountain D, Ralston M, Higgins N, Gorlin JB, Uhl L, Wheeler C, et al. Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 1977; 37:585 - 591
  • Bielanski A, Nadin-Davis S, Sapp T, Lutze-Wallace C. Viral contamination of embryos cryopreserved in liquid nitrogen. Cryobiology 2000; 40:110 - 116
  • Kyuwa S, Nishikawa T, Kaneko T, Nakashima T, Kawano K, Makamura N, et al. Experimental evaluation of cross contamination between cryotubes containing mouse 2-cell embryos and murine pathogens in liquid nitrogen tanks. Exp Animals 2003; 52:67 - 70
  • Grout BWW, Morris GJ. Contaminated liquid nitrogen vapour as a risk factor in pathogen transfer. Theriogenology 2009; 71:1079 - 1082
  • Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, et al. Catastrophic failures of freezing bags for cellular therapy products: description, cause and consequences. Cytotherapy 2002; 4:539 - 549
  • Qadry SS, Roshdy TH, Char H, Del Terzo S, Tarantino R, Moschera J. Evaluation of CZ-resin vials for packaging protein-based parenteral formulations. Int J Pharm 2003; 252:207 - 212
  • Esfandiary R, Joshi SB, Vilivalam V, Middaugh CR. Characterization of protein aggregation & adsorption on prefillable syringe surfaces 2008; Presented at: AAPS National Biotechnology Conference Toronto, Canada
  • Waxman L, Vilivalam V. Development of analytical techniques to determine protein adsorption on sterilized parenteral packaging containers and stoppers 2009; Presented at: AAPS National Biotechnology Conference Seattle WA
  • Bielanski A. Non-transmission of bacterial and viral microbes to embryos and semen stored in the vapour phase of liquid nitrogen in dry shippers. Cryobiology 2005; 50:206 - 210
  • Stacey GN. Cell contamination leads to inaccurate data: we must take action now. Nature 2000; 403:356
  • Ahrlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009; 4:20 - 26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.